# A Study of LY3537031 in Overweight, Obese, and Healthy Participants

> **NCT06606106** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 302 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** LY3537031
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06606106
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-05
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 302 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06606106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06606106, "A Study of LY3537031 in Overweight, Obese, and Healthy Participants". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06606106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*